Health Technology · Pharmaceuticals: Major · NSE: ORTINGLOBE · data 2026-10-09

Ortin Global Ltd

Health check: Weak (0.8/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹13.83

Market cap

₹12 cr

P/E

—

P/B

—

ROE

-46.1%

ROCE

-46.3%

Debt / equity

0.81

Dividend yield

0.00%

1-year return

10.0%

52-week high

₹21.3

52-week low

₹10.66

Operating margin

-1521.1%

Growth

Revenue (last 12 months)	₹0 cr
Net profit (last 12 months)	₹-1 cr
Sales growth, 3 years (yearly)	-74.4%
Profit growth, 3 years (yearly)	—

Similar companies

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) · Medicamen Organics Ltd. (MEDIORG) · Medi-Caps Ltd. (MEDICAPQ) · Lasa Supergenerics Ltd. (LASA) · Sunrest Lifescience Limited (SUNREST)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ORTINGLOBE in NSE Scanner →